A 75 year old man with long-standing rheumatic mitral stenosis who refused surgical intervention was treated with percutaneous balloon valvuloplasty. Prevalvuloplasty evaluation revealed a heavily calcified mitral valve, a mean transvalvular gradient of 18 mm Hg, a Fick cardiac index of 1.7 liters/min per m 2 , a mitral valve area of 0.6 cm 2 and 1 + mitral regurgitation. After transseptal catheterization and balloon dilation of the interatrial septum with an 8 mm angioplasty balloon, a 25 mm valvuloplasty balloon was advanced over a guide wire across the interatrial septum and positioned across the mitral anulus. Subsequent balloon inflation at 3 atm pressure resulted in a reduction of the mean mitral valve gradient to 12 mm Hg, an increase in cardiac index to 2.5 liters/min per m 2 , an increase in mitral valve area in 1.4 cm 2 and an increase in mitral regurgitation from Percutaneous balloon angioplasty is a commonly used technique in invasive cardiology and to date has been applied successfully in the dilation of peripheral arteries (I), renal (2) and coronary (3) artery stenoses, hypoplastic and stenotic pulmonary arteries (4), aortic coarctations (5) and venous obstructions (6). In addition, several investigators have used balloon dilation successfully in the treatment of valvular stenoses, including congenital pulmonary stenosis (7), congenital aortic stenosis (8) and rheumatic mitral stenosis in young patients (9). Although balloon valvuloplasty appears to be a safe and effective technique in relatively young patients, the efficacy of this technique has not been tested
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Repeat catheterization 2 months after valvuloplasty showed further resolution of pulmonary hypertension and no evidence of valvular restenosis or worsening mitral regurgitation, but detected a small atrial septal defect with a pulmonary to systemic blood flow ratio of 1.8. It is concluded that percutaneous valvuloplasty is possible in the adult patient with calcific rheumatic mitral stenosis, and may result in a significant improvement in valvular function without producing life-threatening complications.
(J Am Coil CardioI1986; 7:1410-S) adequately in older adult patients with long-standing calcified valvular obstruction. Accordingly, we tested the applicability of balloon valvuloplasty in a 75 year old patient with long-standing rheumatic mitral stenosis.
Case Report

Clinical History
The patient is a 75 year old white man with long-standing rheumatic mitral valve disease who was admitted to the Beth Israel Hospital with right and left heart failure. Prior medical history was notable only for severe chronic obstructive lung disease. Twelve months before admission, the patient presented with mild left heart failure and murmurs of mitral stenosis and regurgitation. Echocardiographic studies demonstrated rheumatic mitral stenosis and regurgitation, a dilated left atrium (5.8 cm) and findings compatible with right ventricular pressure overload and secondary tricuspid regurgitation. The patient was treated with furosemide and his condition improved. Eleven months before admission, he was admitted with symptomatic episodes of sinus bradycardia and complete heart block, ultimately requiring im-plantation of a permanent dual chamber (DDD) cardiac pacemaker. Four months before admission, he presented with chest pain and congestive heart failure. There was no evidence of oiyocardial infarction. After treatment with increasing doses of diuretic drugs and the addition of captopril to his regimen, there was mild improvement in his symptomatic status. After discharge to an intermediate care facility, he developed increasing dyspnea, hemoptysis and dysphagia. He was subsequently seen in our emergency ward and was admitted because of severe right and left heart failure.
Physical examination. The findings at the time of admission included a blood pressure of 100/60 mm Hg, a heart rate of 100 beats/min, a labored respiratory rate of 28/min and no temperature elevation. The patient appeared chronically ill with marked wasting and cachexia. The jugular venous pressure was elevated to 16 cm H 2 0. Carotid upstrokes were normal. Lung examination revealed dullness to percussion over both lung bases with bilateral rales onethird to one-half way up. Cardiac auscultation revealed a loud first heart sound followed by a grade 2/6 holosystolic murmur of mitral regurgitation. The pulmonary component of the second heart sound was increased, and there was a soft opening snap and a faint diastolic rumble of mitral stenosis. There was a soft systolic ejection murmur at the lower left sternal border that radiated to the base of the heart, but there was no evident aortic insufficiency. Abdominal examination demonstrated an enlarged liver that was not tender. There was 4 + pitting edema of both lower limbs up to midthigh. Neurologic examination was normal.
Initial laboratory studies. Complete blood count, platelet count, prothrombin time, serum electrolytes, blood urea nitrogen, serum creatinine, liver transaminases and bilirubin were normal. Chest X-ray films showed an enlarged heart, a prominent right heart border and a dilated left atrium; there was pulmonary vascular engorgement and a sizable right-sided pleural effusion. An electrocardiogram revealed a heart rate of 100 beats/min, which was 100% paced in the DDD mode. Arterial blood gas determination on 2 liters/min of oxygen included a pH of 7.47, a partial pressure of oxygen (Po 2 Surgical evaluation. Despite continued administration of large doses of intravenous diuretic drugs, the symptoms of dyspnea and hemoptysis did not improve. The patient was evaluated by the cardiovascular surgery staff who thought that the mitral valve could be replaced but that the expected risk of surgical intervention would be high. Mitral valve replacement was recommended, but the patient refused.
Because the patient was severely limited by dyspnea, consideration was given to treatment of the mitral stenosis by percutaneous balloon valvuloplasty. The patient accepted the procedure and informed consent was obtained under a protocol approved by the Beth Israel Human Studies Committee after the potential risks and benefits were explained to the patient.
Balloon Valvuloplasty Procedure
The patient was brought to the catheterization laboratory and his left femoral artery and left and right femoral veins were instrumented with 8F Hemokit sheaths (USCI) under local anesthesia. Left and right heart catheterization with a 7F pigtail catheter and 7F balloon flotation catheter were subsequently performed from the left groin. During the right heart catheterization, a diagnostic oxygen saturation series was obtained. After placement of the left and right heart catheters, measurements were made of baseline hemodynamics. The pulmonary capillary wedge position was confirmed by aspiration of blood with an oxygen saturation of 96%. Oxygen consumption was estimated at 125 mIl min per m 2 because the patient was receiving supplemental oxygen. After the completion of pressure measurements, left ventriculography was performed in the routine manner.
After prevalvuloplasty measurements, a 7F MuIlirts transseptal long sheath and dilator (USCI) were advanced from the right femoral vein over a guide wire and positioned in the superior vena cava. A standard Brockenbrough needle was advanced to the tip of the dilator, both the needle and dilator were withdrawn to the fossa ovalis of the right atrium anG the left atrium was then entered by advancing the needle under C-arm fluoroscopic control. Correct needle position in the left atrium was confirmed with oximetry, pressure measurement and contrast injection, and the sheath and dilator were then advanced. The needle and dilator were removed and a 7F balloon-tipped end-hole catheter was advanced from the sheath to the left atrium. Left heart pressures and transvalvular gradients were then measured directly to corroborate the previously obtained wedged pressure measurements. The 7F balloon catheter was advanced through the mitral and aortic valves to the descending aorta, followed by insertion of a 0.038 inch (0.097 cm), 300 cm long Teflon-coated exchange guide wire (Cook, Inc.) through the flowdirected catheter. The sheath and balloon catheter were then removed, leaving only the guide wire in place.
Next, an 8F angioplasty catheter (Mansfield Scientific) with an 8 mm balloon was advanced over the guide wire to the level of the interatrial septum and used to dilate the septum. After removal of this catheter, a 9F balloon dilation catheter (Mansfield Scientific) with a 25 mm balloon was advanced across the septum through the left atrium and positioned across the mitral anulus. Three 15 to 30 second balloon inflations with a mixture of saline solution and iodinated contrast medium (Angiovist 282) were then performed at 3· atm pressure with continuous monitoring of pulmonary artery and systemic arterial pressures. During the first two inflations, the balloon was positioried too distally (that is, in the left ventricular cavity); during the third inflation, a waist was seen in the balloon at the level of the mitral villve which subsequently disappeared during maximal inflation at 3 atm.
Immediately after catheter commissurotomy, all hemodynamic measurements including determinations of transvalvular gradient and cardiac output were repeated. Left ventriculography was also repeated to assess the degree of mitral regurgitation, and a complete right heart oximetry series was repeated to look for evidence of a new left to right atrial shunt. Two months after valvuloplasty, repeat catheterization was performed to reassess hemodynamics.
Results
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June 1986:1410-5 Postvalvuloplasty data. The patient tolerated mitral valve dilatiori well without evidence of embolic phenomena at the time of the procedure and in the 6 months after valvuloplasty. He continued to receive furosemide and captopril, and duriIig the 3 week period after valvuloplasty, diuresis resulted in a weight ioss of 18 kg. The patient reported significant alleviation of dyspnea and increased exercise tolerance and was discharged to his home. Table 1 summarizes hemodynamic measurements before and after percutaneous mitral valvuloplasty. Major immediate changes produced by the valvuloplasty procedure included a decrease iIi mean transvalvular gradient from 18 to 12 mm Hg, an increase in cardiac index from 1. 7 to 2.5 liters/min per m 2 and an increase in calculated mitral valve area from 0.6 to 1.4 cm 2 • Right heart oximetry series showed no evidence of a significant oxygen step-up before and immediately after valvuloplasty. Serial left ventriculography demonstrated a mild increase in mitral regurgitation from 1 + to 2 + . Figure 1 shows left ventricular and pulmonary capillary wedge pressures before and after valvuloplasty. Figure 2 shows the valvuloplasty balloon being inflated within the mitral valve.
Follow-up cardiac catheterization. 
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PERCUT "'NEOLIS MITRAL v ALVlILOPLASTY however. demonstrated a significant oxygen step-up with a calculated pulmonary to systemic blood flow ratio of 1.8. This interatrial shunt was well tolerated as evidenced by a marked decrease in right and left heart filling pressures and a marked decrease in pulmonary vascular resistance.
Discussion
The technique of percutaneous mitral commissurotomy through a transseptal approach has been described previously by Lock et al. (9), who perfonned successful balloon valvuloplasty in eight children and young adults (aged 9 to 23 years) with moderate to severe mitral stenosis. Patients with evidence of mitral regurgitation or mitral calcification, however. were excluded. This case study complements the report of Lock et al. and has documented that in at least one patient with long-standing calcific rheumatic mitral stenosis. balloon valvuloplasty may result in significant improvement in valvular function without the production of severe mitral regurgitation or emboli. umented the successful use of a surgically introduced balloon catheter to dilate stenotic mitral valves. Because simple separation of fused mitral leaflets by blunt pressure results in a marked increase in effective orifice area, it follows that this pressure might be applied by way of a percutaneously introduced balloon catheter without thoracotomy. The theoretic risks involved in this technique would include the potential complications associated with commissurotomy, plus the added risks of the balloon dilation procedure.
In particular. the risks include: I) creation of a significant atrial septal defect secondary to dilation of the interatrial septum to allow accommodation of a relatively large valvuloplasty balloon; 2) problems arising from the positioning of a valvuloplasty balloon across a tightly stenotic mitral valve; 3) short-term hemodynamic deterioration during balloon occlusion of the mitral valve orifice; 4) systemic embolization of left atrial thrombus or mitral valve debris; 5) creation of severe mitral regurgitation; and 6) mitral restenosis. All of these risks must be added to the usual risks of bilateral heart catheterization and transseptal catheterization.
With respect to atrial septal defect creation. it is notable that in this case study a small interatrial shunt was detected 2 months after the procedure. The marked decrease in the patient's filling pressures and pulmonary vascular resistance. however. suggest that the deleterious effect of this interatrial communication was minimal. This shunt may not have been apparent immediately after valvuloplasty because of the elevated right atrial pressure at the time of the pro- Figure 2 . Photograph of the 25 mm valvuloplasty balloon being inflated within the mitral anulus, cedure and the subsequent lack of a pressure gradient across the interatrial septum. Acute shunt creation could be particularly deleterious in patients with long-standing pulmonary hypertension secondary to mitral stenosis, because the added volume load on the patient's right ventricle could theoretically lead to worsening hemodynamic consequences. Of note, in the previous series of children and young adults (9) , no significant right to left shunt was detected by oximetry after valvuloplasty.
Perhaps one of the most worrisome concerns surrounding valvuloplasty is the possibility of embolization of clot or valvular debris during or after balloon dilation. For this reason, when potential valvuloplasty candidates undergo echocardiography, special attention should be directed to detection of left atrial thrombus that might embolize during the valvuloplasty procedure. In such patients, perhaps, any percutaneous balloon dilation procedure should be deferred. It is notable that other investigators have not observed embolic phenomena during valvular dilations in children and adolescents. However, the potential for valvular debris may be significantly greater in older patients with heavily calcified valves. Currently, our institution is engaged in the in vitro dilation of postmortem or surgically excised valves to assess embolization potential, but clearly more work is needed in this area.
Another major concern surrounding mitral valvuloplasty is the potential problem of inducing mitral regurgitation.
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In the previous series (9), significant mitral regurgitation was not observed. In our patient, mitral regurgitation increased from I + to 2 + by angiographic assessment. It seems clear from this preliminary work, and from reports on closed or open mitral commissurotomy, that new or increased mitral regurgitation will occur in a significant number of patients after balloon dilation, As a result, patients with moderate to severe regurgitation should not be considered candidates for this procedure.
A final concern surrounding mitral valvuloplasty is the potential for mitral valve restenosis. The incidence of restenosis after surgical commissurotomy has been estimated to range from 2 to 60%, with approximately 10% of patients requiring reoperation in 5 years and 60% within 10 years (10-15). It seems likely that significant restenosis rates will also occur after balloon valvuloplasty.
Conclusion. Percutaneous balloon valvuloplasty may be possible in selected patients with long-standing rheumatic mitral stenosis who are at an increased risk for surgical mitral valve replacement. The procedure can improve hemodynamic status by increasing mitral valve orifice area, and may have a lower risk of morbidity and mortality than mitral valve surgery. Patients with moderate to severe mitral regurgitation and those with left atrial thrombus should be excluded from consideration for the procedure. Additional studies are needed to further assess the safety and long-term efficacy of this procedure.
